Patient Factors But Not the Use of Novel Anticoagulants or Warfarin Are Associated With Internal Jugular Vein Access-Site Hematoma After Right Heart Catheterization.

CONCLUSION: The incidence of internal jugular vein access-site hematoma is small when using careful access techniques for RHC even with the continued use of novel oral anticoagulants and warfarin. Patient characteristics and co-morbid conditions are related to bleeding complications. PMID: 29207361 [PubMed - in process]
Source: The Journal of Invasive Cardiology - Category: Cardiology Tags: J Invasive Cardiol Source Type: research

Related Links:

Authors: Liu Z, Chai E, Chen H, Huo H, Tian F Abstract BACKGROUND The aim of this study was to analyze the changing role of thrombelastography (TEG) by detecting the indexes of TEG in patients with acute cerebral hemorrhage and cerebral infarction, combined with pathogenesis, and to find objective laboratory indexes for the diagnosis and treatment of cerebrovascular diseases. MATERIAL AND METHODS Data from 150 patients were collected, including 69 cases identified as the cerebral infarction group and 81 cases identified as the cerebral hemorrhage group. In addition, 50 healthy adults were selected as a control grou...
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
ConclusionIn this single-center retrospective study, SIPAT did not predict cumulative re-admissions. Further study is required to validate SIPAT before clinical implementation.
Source: Heart and Lung: The Journal of Acute and Critical Care - Category: Respiratory Medicine Source Type: research
ConclusionThe results that were obtained, i.e. approximately 0.8 ml/cm2 of excised and grafted skin, are similar to those of other published studies, which concerned specific populations such as pediatrics. Determining blood loss in one centre can help physicians to calculate the excisable area without any transfusion. However, blood loss can vary widely between patients and one must consider individual clinical situation to provide safe surgery.
Source: Burns - Category: Dermatology Source Type: research
(MedPage Today) -- All-cause and cancer-related mortality higher with aspirin; so were bleeding events
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
Anticoagulation for prosthetic valve in pregnancy – Cardiology MCQ – Answer Anticoagulation regimen in pregnancy with prosthetic valve associated with lowest rate of fetal or neonatal loss: Correct answer: d) Low molecular weight heparin Low molecular weight heparin is associated with lowest rate of fetal or neonatal loss in pregnancy with prosthetic valve, but has a higher risk of valve thrombosis [1]. Though the often followed method is initial use of unfractionated heparin followed by warfarin in second trimester followed by unfractionated heparin in peripartum period, this approach has higher maternal...
Source: Cardiophile MD - Category: Cardiology Authors: Tags: Uncategorized Source Type: blogs
Authors: Clarke A, Ibrahim A, Kiernan TJ Abstract INTRODUCTION: Patients with atrial fibrillation taking oral anticoagulation and undergoing percutaneous coronary intervention with stent insertion are recommended to receive antithrombotic therapy with aspirin and P2Y12 receptor antagonist. This combinatory regime encompasses triple therapy (TT). Although TT reduces the risk of ischaemic events such as stroke and stent thrombosis, it is associated with an increased bleeding risk. Areas covered: The efficacy and safety profile of TT is uncertain with undetermined optimal duration and therapeutic combination. This rev...
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research
CONCLUSIONS: MIDLF was the least invasive, and there was no significant difference between the three groups in terms of fusion, screw loosening, and clinical outcomes. PMID: 30213170 [PubMed]
Source: Asian Spine Journal - Category: Orthopaedics Tags: Asian Spine J Source Type: research
Authors: Sebaaly A, Najjar A, Wang Z, Boubez G, Masucci L, Shedid D Abstract STUDY DESIGN: Retrospective case series. PURPOSE: To evaluate the clinical and radiological efficacy of anterolateral kyphoplasty for cervical spinal metastasis. OVERVIEW OF LITERATURE: Although the spine is the third most common site of tumor metastasis, the cervical spine is the least commonly affected (incidence, 10%-15%). Surgical decompression is highly challenging because of the proximity of neural and vascular elements. Kyphoplasty for cervical spine metastasis has been described in small case reports with promising results....
Source: Asian Spine Journal - Category: Orthopaedics Tags: Asian Spine J Source Type: research
We describe two clinical cases of spontaneous choroidal hemorrhage in patients treated with direct oral anticoagulants (rivaroxaban and dabigatran etexilate) for atrial fibrillation. These cases show that an ocular hemorrhagic risk exists with these drugs. Patients treated with DOAC should have the therapeutic dose adjusted based on creatinine clearance. Special monitoring should be performed in patients with age-related macular degeneration or with hypertension even though meta-analysis shows that the risk of intraocular bleeding is reduced by 22% compared with warfarin. PMID: 30213607 [PubMed - as supplied by publisher]
Source: Journal Francais d Ophtalmologie - Category: Opthalmology Tags: J Fr Ophtalmol Source Type: research
This study is registered with ClinicalTrials.gov, number NCT01619085, and with EudraCT, number 2011-002766-21.FindingsThe first patient was enrolled into INPULSIS-ON in July 2, 2012. Of 807 patients who completed the INPULSIS trials, 734 (91%) were treated in INPULSIS-ON. 430 (59%) patients had received nintedanib in INPULSIS and continued nintedanib in INPULSIS-ON, and 304 (41%) had received placebo in INPULSIS and initiated nintedanib in INPULSIS-ON. Median exposure time for patients treated with nintedanib in both the INPULSIS and INPULSIS-ON trials was 44·7 months (range 11·9–68·3). The safet...
Source: The Lancet Respiratory Medicine - Category: Respiratory Medicine Source Type: research
More News: Bleeding | Cardiac Catheterization | Cardiology | Coumadin | Databases & Libraries | Dialysis | Heart | Laboratory Medicine | Statistics | Ultrasound | Warfarin